Embryonal carcinoma of the central nervous system Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

2 events

Mar 2025Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Tango Therapeutics, Inc. — PHASE1, PHASE2

TrialRECRUITING

Feb 2025Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Mayo Clinic — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Embryonal carcinoma of the central nervous system.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1PHASE1, PHASE2

1Total recruiting

Search clinical trials for Embryonal carcinoma of the central nervous system →

Recent News & Research

No recent news articles indexed yet for Embryonal carcinoma of the central nervous system.
Search PubMed for Embryonal carcinoma of the central nervous system →

Browse all Embryonal carcinoma of the central nervous system news →

Specialist Network

Top 6 by expertise

Robert J. Motzer, MD, MD

Memorial Sloan Kettering Cancer Center

📍 NEW YORK, NY

Score 129 trials

Amanda Olson

M.D. Anderson Cancer Center

Score 122 trials19 pubs

Jing Li

M.D. Anderson Cancer Center

Score 82 trials1557 pubs

Philip Wong, MD, FRCPC

Centre hospitalier de l'Université de Montréal (CHUM)

Score 41 trial

Maxim Pimkin, MD, PhD, MD, PhD

Tango Therapeutics, Inc.

📍 PITTSBURGH, PA

Score 41 trial

Paul B. Chapman, MD

Memorial Sloan Kettering Cancer Center

Score 43 trials

View all Embryonal carcinoma of the central nervous system specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰